Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

This session will address post-marketing periodic reports, including the US Periodic Adverse Drug Experience Report (PADER) and the EU Periodic Safety Update Report (PSUR in ICH Periodic Benefit Risk Evaluation Report format), with a cameo description of the “old” format PSUR still required in some jurisdictions.